Article info

Download PDFPDF

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Authors

  1. Correspondence to Professor Josef S Smolen, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna A-1090, Austria; josef.smolen{at}meduniwien.ac.at
View Full Text

Citation

Smolen JS, Landewé RBM, Bijlsma JWJ, et al
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Publication history

  • Received November 17, 2019
  • Revised December 16, 2019
  • Accepted December 18, 2019
  • First published January 22, 2020.
Online issue publication 
May 20, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.